This study validates and expands on our previous work that assessed three-dimensional (3D) nuclear telomere profiling in buccal cells of Alzheimer’s disease (AD) patients and non-AD controls (Mathur et al., J Alzheimers Dis 39, 35–48, 2014). While the previous study used age- and gender-matched caregiver controls, the current study consented a new cohort of 44 age- and gender-matched healthy non-caregiver controls and 44 AD study participants. 3D telomeric profiles of buccal cells of AD patients and their non-AD controls were examined with participant information blinded to the analysis. In agreement with our previous study, we demonstrate that 3D telomeric profiles allow for the distinction between AD and non-AD individuals. This validation cohort provides an indication that the total number of 3D telomeric signals and their telomere lengths may be a suitable biomarker to differentiate between AD and non-AD and between mild, moderate, and severe AD. Further studies with larger sample sizes are required to move this technology further toward the clinic.
Alzheimer’s Association (2014) 2014 Alzheimer’s Disease Facts and Figures, Alzheimers Dement10, e47–1783.
2.
HebertL, WeuveJ, ScherrP, EvansD (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 Census, Neurology80, 1778–1783.
3.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology34, 939–944.
4.
JackCR, AlbertMS, KnopmanDS, McKhannGM, SperlingRA, CarrilloMC, ThiesB, PhelpsCH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s Disease, Alzheimers Dement7, 257–262.
5.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement7, 270–279.
6.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCR, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging - Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement7, 263–269.
7.
HanninenT, HallikainenM, TuomainenS, VanhanenM, SoininenH (2002) Prevalence of mild cognitive impairment: A population-based study in elderly subjects, Acta Neurol Scand106, 148–154.
TanL, YuJ, LiuQ, TanM, ZhangW, HuN, WangY, SunL, JiangT, TanL (2014) Circulating miR-125b as a biomarker of Alzheimer’s disease, J Neurol Sci336, 52–56.
10.
NasreddineZS, PhillipsNA, BedirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (1995) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment, J Am Geriatr Soc53, 695–699.
11.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res12, 189–198.
12.
McDowellI, KristjanssonB, HillGB, HebertR (1997) Community screening for dementia: The Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared, J Clin Epidemiol50, 377–383.
13.
BoustaniM, PetersonB, HansonL, HarrisR, LohrK (2003) Screening for dementia in primary care: A summary of the evidence for the U.S. Preventative Services task force, Ann Intern Med138, 927–937.
GellerLN, PotterH (1999) Chromosome missegregation and trisomy 21 mosaicism in Alzheimer’s diseas, Neurobiol Dis6, 167–179.
16.
MiglioreL, TestaA, ScarpatoR, PaveseN, PetrozziL, BonuccelliU (1997) Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer’s Disease, Hum Genet101, 299–305.
17.
ThomasP, FenechM (2008) Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer’s disease, Mutagenesis23, 57–65.
18.
PanossianLA, PorterVR, ValenzuelaHF, ZhuX, RebackE, MastermanD, CummingsJL, EffrosRB (2003) Telomere shortening in T cells correlates with Alzheimer’s disease status, Neurobiol Aging24, 77–84.
19.
ForeroDA, González-GiraldoY, López-QuinteroC, Castro-VegaLJ, BarretoGE, PerryG (2016) Meta-analysis of telomere length in Alzheimer’s disease, J Gerontol A Biol Sci Med Sci71, 1069–1073.
20.
WatsonJD (1972) Origin of concatemic T7 DNA, Nat New Biol239, 197–201.
21.
OlovnikovAM (1972) The immune response and the process of marginotomy in lymphoid cells, Vestn Akad Nauk SSSR27, 85–87.
22.
KrukPA, RampinoNJ, BohrVA (1995) DNA damage and repair in telomeres: Relation to aging, Proc Natl Acad Sci U S A92, 258–262.
23.
de LangeT (2005) Shelterin: Therotein complex that shapes and safeguards human telomeres. Genes Dev19, 2100–2110.
24.
ThomasP, O’CallaghanNJ, FenechM (2008) Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer’s disease, Mech Ageing Dev129, 183–190.
25.
GadjiM, Adebayo AweJ, RodriguesP, KumarR, HoustonDS, KlewesL, DièyeTN, RegoEM, PassettoRF, de OliveiraFM, MaiS (2012) Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups, Clin Cancer Res18, 3293–3304.
26.
KnechtH, KongruttanachokN, SawanB, BrossardJ, PrévostS, TurcotteE, LichtensztejnZ, LichtensztejnD, MaiS (2012) Three-dimensional telomere signatures of Hodgkin- and Reed-Sternberg cells at diagnosis identify patients with poor response to conventional chemotherapy, Transl Oncol5, 269–277.
27.
VermolenB, GariniY, MaiS, MougeyV, FestT, ChuangT, ChuangA, WarkL, YoungI (2005) Characterizing the three-dimensional organization of telomeres, Cytometry A67, 144–150.
28.
HayflickL (1965) The limited in vitro lifetime of human diploid cell strains, Exp Cell Res37, 614–636.
RazV, VermolenBJ, GariniY, OnderwaterJJ, Mommaas-KienhuisMA, KosterAJ, YoungIT, TankeH, DirksRW (2008) The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells, J Cell Sci121(Pt 24), 4018–4028.
31.
KimMJ, KimMH, KimSA, ChangJS (2008) Age-related deterioration of hematopoietic stem cells, Int J Stem Cells1, 55–63.
32.
PatelPL, SuramA, MiraniN, BischofO, HerbigU (2016) Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence, Proc Natl Acad Sci U S A113, E5024–E5033.
33.
IshikawaN, NakamuraK, Izumiyama-ShimomuraN, AidaJ, MatsudaY, AraiT, TakuboK (2016) Changes of telomere status with aging: An update, Geriatr Gerontol Int Suppl1, 30–42.
34.
SeimiyaH (2015) Predicting risk at the end of the end: Telomere G-tail as a biomarker, EBioMedicine2, 804–805.
35.
MaiS (2010) Initiation of telomere-mediated chromosomal rearrangements in cancer, J Cell Biochem109, 1095–1102.
36.
MathurS, GlogowskaA, McAvoyE, RigholtC, RutherfordJ, WillingC, BanikU, RuthirakuhanM, MaiS, GarciaA (2014) Three-dimensional quantitative imaging of telomeres in buccal cells identifies mild, moderate, and severe Alzheimer’s disease patients, J Alzheimers Dis39, 35–48.
37.
PoonSS, MartensUM, WardRK, LansdorpPM (1999) Telomere length measurements using digital fluorescence microscopy, Cytometry36, 267–278.
38.
SchaeferLH, SchusterD, HerzH (2001) Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy, J Microsc204, 99–107.
39.
DamjanovicAK, YangY, GlaserR, Kiecolt-GlaserJK, NguyenH, LaskowskiB, ZouY, BeversdorfDQ, WengNP (2007) Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer’s disease patients, J Immunol179, 4249–4254.
40.
O’DonovanA, TomiyamaAJ, LinJ, PutermanE, AdlerNE, KemenyM, WolkowitzOM, BlackburnEH, EpelES (2012) Stress appraisals and cellular aging: A key role for anticipatory threat in the relationship between psychological stress and telomere length, Brain Behav Immun26, 573–579.
